Clinical Trial Update: Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to Triple Therapy

View source ↗

Summary

A completed clinical trial comparing tiotropium and olodaterol versus triple therapy for chronic obstructive pulmonary disease, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Triple therapy
• olodaterol (olodaterol)
• tiotropium (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED | Results posted: 2020-11-30